SlideShare a Scribd company logo
1 of 35
Various Aspects Of The
Tumor Response To
Radiotherapy In Rectal
Cancer
Authors: Prof. Dr. E. Bratucu
Sinziana Ionescu
Bucharest Oncology Institute
Purpose And Goals
 As rectal tumors answer in different grades to
radiotherapy, we aim at evaluating –right from the
moment of the biopsy- the capacity of the tumor to
react or not to this treatment option
 We find the immunohistochemical evaluation of the
tumor to be of crucial importance and we highly
recommend it to be done on the biopsy before
radiotherapy
Group Of Patients Studied
Patient distribution by sex was equal
between the two sexes, with 26 patients
each.
We examined tissue samples using
paraffin blocks from 52 patients.
The examinations were done
comparatively, both:
-before radiotherapy
(tissues from diagnostic biopsy), as
- after radiotherapy
(tissues from abdomino-perineal
resection).
The patients had received treatment in the following units:
Bucharest Oncology Institute, Coltea, Fundeni and Colentina Hospital
The parametres studied were:
A. histological and
B. immunohistochemical
A.Histological parameters studied
Cell type
distribution
p=0.96
Distribution of the
desmoplastic
reaction p=0.218
Distribution of
atypias
p= 0.910
Distribution of the
colloid type*
p=0,001
*
The only morphological parameter with statistical meaning, using the χ test with
corresponding p value
Cellular type
 Cell shape and architecture are determined by
interactions between the cell and the extracellular
matrix and have profound effects on cellular behavior,
chromatin condensation, and tumor cell resistance to
radiotherapy and chemotherapy.
 Transformation from cylindrical to cubic: oncocytic
change in this particular clinical context occurs as a
reflection of cytotoxic damage or cellular hypoxia
induced by chemo-radiation resulting in degeneration
of the cell and of the oncocytic phenotype.
Cell type distribution before and after radiotherapy was predominantly cylindrical before
radiotherapy(RIB) and cubic after radiotherapy (RIC)
Cylindrical Cubic
RIB 45 7
RIC 8 44
0
10
20
30
40
50
Cell type distribu on before and a er
radiotherapy
RIB
RIC
Desmoplastic reaction
 Desmoplastic reaction has been defined as being
associated with some tumors and is characterized by
the pervasive growth of dense fibrous tissue around the
tumor. This reaction makes it difficult to distinguish
between spiculation in the perirectal fat caused by
fibrosis alone from that caused by fibrous tissue that
contains tumor cells. Cancer associated with a reactive
stroma is typically diagnostic of poor prognosis.
The distribution of desmoplastic reaction before and after radiotherapy: if before
radiotherapy the predominant demoplastic reactions were of grades 1 and 2, after
radiotherapy the predominant desmoplastic reaction becomes 1.
Cellular atypia
 Cellular atypias have been studied in the context of
their association with increased severity of the
neoplasm
 The individual tumor cells in treated rectal cancer may
show marked nuclear atypias .Marked cytoplasmic
eosinophilia, often in association with nuclear atypias is
the most commonly seen type of cytological alteration
in tumors after radiation.
The variation of the distribution of atypia before and after radiotherapy has kept the
same type 2 as the main type of atypia
Colloid type
 Mucinous adenocarcinoma is characterised by
abundant extracellular mucin produced by tumour cells.
By definition, a 50% or greater mucinous component is
required for the designation of mucinous colorectal
carcinoma . The prognostic significance of mucinous
carcinoma is controversial, many authors associating it
with a poor prognosis in which regards
chemoradiotherapy.
Tissues after radiotherapy
Non-colloid type Colloid type
Tissues after radiotherapy
Non-colloid type Colloid type
Mucinous, Colloid and Signet ring cell types seen
in the tissues after radiotherapy
The variation in the distribution of the colloid response
before and after radiotherapy changes consistently
from dominant 0 to dominant 1.
Colloid type
 The increase of the colloid type from 0 to 1 would lead us
towards the assumption that radiotherapy either induced or
aggravated the expression of the colloid type
 The literature used as reference showed that those cancers
which appeared to have been induced by radiotherapy had
mostly colloid features, therefore in a patient which was
irradiated for prostate cancer , we could estimate weather the
neoplasm appeared d’en blais or consequently to
radiotherapy
I.MARKERS OF STATISTICAL IMPORTANCE
EGFR in the
tumor
(p=0.00045)
EGFR in the
normal
epithelium
(p=0.0017)
VEGF in the
tumor
(p=0,0132)
VEGF in the
tumor
stroma
(p=0,030).
P53
(p=0,044)
B.Immunohistochemical parameters studied
II.MARKERS WITHOUT STATISTICAL IMPORTANCE, WITH OBSERVATION-ONLY
SIGNIFICANCE
CK 7
P=0.6404
CK 20
P=0.278
E-cadherin
P=0.368
Vimentin
P value was not
calculated, as all
the tissues had the
0 value.
CEA
BCL 2 CYCLIN D1
EGFR si VEGF-part 1
 EGFR (epidermal growth factor receptor) exists on the cell
surface as a transmembrane glycoprotein , a member of the
protein kinase superfamily. This protein is a receptor for
members of the epidermal growth factor family.and is
activated by binding of its specific ligands, including
epidermal growth factor and transforming growth factor α
(TGFα). Mutations, amplifications or misregulations of EGFR
or family members are implicated in about 30% of all
epithelial cancers. The identification of EGFR as an
oncogene has led to the development of anticancer
therapeutics directed against EGFR, including gefitinib and
erlotinib for lung cancer, and cetuximab for colon cancer.
EGFR si VEGF part 2
 Current findings have demonstrated that alterations in
tumor stromal pathways, including the EGFR pathways,
are associated with, and may contribute to, resistance to
VEGF inhibitors and that targeting these pathways may
improve therapeutic efficacy. Understanding stromal
signaling may be critical for developing biomarkers for
angiogenesis inhibitors and improving combination
regimens and this is the reason why we chose to study
EGFR and VEGF both at the level of the tumor and at the
level of the stroma and the grades are given according to
appreciation of two independent examining doctors
regarding the amount of EGFR and VEGF in the tissue
studied.
The variation with radiotherapy of EGFR in the tumor: the tissues before radiotherapy
had similar numbers of grades 1 and 2 and after radiotherapy grade 2 was the main grade
found among the tissues examined
EGFR in the tumor increased by a mean of 1 unit
EGFR in the normal epithelium before and
after radiotherapy
0
5
10
15
20
25
30
35
0
1
2
3
0 1 2 3
RIC 15 19 12 6
RIB 17 7 10 18
EGFR in the normal epithelium before and after
radiotherapy
RIC
RIB
Comparison between EGFR in the tissues
before(RIB) and after radiotherapy(RIC)
(RIB)
(RIC)
Comparison between EGFR in the tissues
before(RIB) and after radiotherapy(RIC)
(RIB) (RIC)
RIB RIC
Observation and specification of EGFR
examination
 EGFR in the normal stroma increases its expression in
the smooth muscle and nervous fibres normal tissues
which appear to be modified by irradiation with a χ of
0,0002 and a corresponding p value of 0.02.
 These results (increased EGFR in the tumor, in the
normal epithelium and in the normal stroma) may have
clinical impact in a negative way, as patients with
increased postradiotherapy EGFR had decreased
overall survival and decreased disease free interval
Comparison between VEGF in the tissues
before(RIB) and after radiotherapy(RIC)
RIB
RIC in the normal mucosa
RIC in the tumor
VEGF in the tumor before and after radiotherapy
VEGF in the tumor stroma before and after radiotherapy
RIB
RIC
0
5
10
15
20
25
GRADE 0 GRADE 1 GRADE 2 GRADE 3
RIB 12 10 11 19
RIC 10 22 12 8
VEGF in the tumor stroma
RIB
RIC
Comparison between the VEGF values before and after radiotherapy at the tumor
level(first pile to the left of the viewer) and at the level of the tumor stroma (pile at the
right of the viewer).
RIB
0
20
40
GRADE 0
GRADE 1
GRADE 2
GRADE 3
GRADE 0
GRADE 1
GRADE 2
GRADE 3
Varia on with radiotherapy of the
values of the VEGF in the tumor and
in the tumor stroma
RIB
RIC
Observation
 The increase of VEGF with radiotherapy in the tumor
and in the tumor stroma was demonstrated also by
other studies, those indicating the correlation between
the increase in VEGF and: larger lymph node invasion,
larger expansion of the tumor growth, bigger rate of
radiation proctitis
Out of 52 cases, in 4 , we have observed CEA becoming negative, a fact which could
imply that in irradiated rectal tumors, a loss of the CEA expression would mislead us
between a tumor which does not express it and a tumor that has disappeared with
radiotherapy (we may mistake a change in tumor biology by a maximum tumor
regression grade)
CYCLIN D1 has a trend in becoming positive with radiotherapy. Cyclins regulate the
progression of the cell through the cell cycle from G1 to S phase
BCL2 shows a cell which is not able to enter an apoptosis. The expression of BCL-2 is
lost in moderately and weakly differentiated tumors and kept in well differentiated ones.
There is a vague increasing trend with radiotherapy from which we infer that
radiotherapy would lead to a change in tumor biology. The integrity of the mitochondrial
outer membrane is regulated by pro-apoptotic and anti-apoptotic members of the BCL2
family of proteins
Observations regarding the parameters without statistical significance
Conclusions part 1
 The following morphological factors studied in our batch did not
present with statistical significance so we could neither
demonstrate nor quantify the influence of radiotherapy on them:
cell type, desmoplastic reaction, atypias. On the other hand, the
colloid type suffered a marked change with radiotherapy
becoming in the majority of the cases from 0- 1 .
 Other markers of statistical significance were EGFR at the
tumor level, EGFR in the tumor stroma, EGFR in the normal
epithelium and they all increased. Moreover, EGFR increased
in expression in the smooth muscle fibers and nervous fibres
demonstrating the involvement of the normal stroma in the
response to radiotherapy . Another marker which was modified
with radiotherapy was VEGF in the tumor and VEGF in the
tumor stroma.
Conclusions -part 2
 The results are similar in trend to those in the
scientific literature consulted in which concerns EGFR
and VEGF.
 Our study has a rather individual and original statement
in comparison to those consulted using the pubmed
index, in which concerns the stromal reaction to
radiotherapy which could be more aggressive and
statistically important than the reaction of the tumor
tissues
Limits and Perspectives
 The most important limit of our study stands in the
small number of cases , mostly in the situations in
which we confronted with the problem of insufficient
tissues
 In which regards future improvements, apart from
extending the number of cases for the markers
studied , it would be interesting to find out their
correlation between overall survival and the disease
free interval in those patients.
We thank Conferee Dr S.Zurac and Professor Dr. F.Staniceanu, from the pathology
department of the Colentina Clinical Hospital for their special collaboration in our study
"ACKNOWLEDGEMENT: This paper is supported by the Sectoral Operational
Programme Human Resources Development (SOP HRD) 2007-2013, financed
from the European Social Fund and by the Romanian Government under the
contract number POSDRU/107/1.5/S/82839",

More Related Content

Similar to TUMOR RESPONSE TO RADIOTHERAPY IN RECTAL CANCER

11.effectiveness of gefitinib as additional radiosensitizer to conventional c...
11.effectiveness of gefitinib as additional radiosensitizer to conventional c...11.effectiveness of gefitinib as additional radiosensitizer to conventional c...
11.effectiveness of gefitinib as additional radiosensitizer to conventional c...
Alexander Decker
 
RADIOTHERAPY FOR BREAST CANCER
RADIOTHERAPY FOR BREAST CANCERRADIOTHERAPY FOR BREAST CANCER
RADIOTHERAPY FOR BREAST CANCER
fondas vakalis
 
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
European School of Oncology
 

Similar to TUMOR RESPONSE TO RADIOTHERAPY IN RECTAL CANCER (19)

Effectiveness of gefitinib as additional radiosensitizer to conventional chem...
Effectiveness of gefitinib as additional radiosensitizer to conventional chem...Effectiveness of gefitinib as additional radiosensitizer to conventional chem...
Effectiveness of gefitinib as additional radiosensitizer to conventional chem...
 
11.[42 53]effectiveness of gefitinib as additional radiosensitizer to convent...
11.[42 53]effectiveness of gefitinib as additional radiosensitizer to convent...11.[42 53]effectiveness of gefitinib as additional radiosensitizer to convent...
11.[42 53]effectiveness of gefitinib as additional radiosensitizer to convent...
 
11.effectiveness of gefitinib as additional radiosensitizer to conventional c...
11.effectiveness of gefitinib as additional radiosensitizer to conventional c...11.effectiveness of gefitinib as additional radiosensitizer to conventional c...
11.effectiveness of gefitinib as additional radiosensitizer to conventional c...
 
MANAGEMENT OF MENINGIOMA
MANAGEMENT OF MENINGIOMAMANAGEMENT OF MENINGIOMA
MANAGEMENT OF MENINGIOMA
 
Rectal Cancer and Radiotherapy: What is the Clinical Implication of a Complet...
Rectal Cancer and Radiotherapy:What is the Clinical Implication of a Complet...Rectal Cancer and Radiotherapy:What is the Clinical Implication of a Complet...
Rectal Cancer and Radiotherapy: What is the Clinical Implication of a Complet...
 
Cross trial
Cross trialCross trial
Cross trial
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancer
 
Lateral lymph nodes in rectal cancer.pptx
Lateral lymph nodes in rectal cancer.pptxLateral lymph nodes in rectal cancer.pptx
Lateral lymph nodes in rectal cancer.pptx
 
EGFR MUTANT NSCLC TTT.pptx
EGFR MUTANT NSCLC TTT.pptxEGFR MUTANT NSCLC TTT.pptx
EGFR MUTANT NSCLC TTT.pptx
 
Panel discussion recurrent cervical cancer
Panel discussion recurrent cervical cancerPanel discussion recurrent cervical cancer
Panel discussion recurrent cervical cancer
 
Efficacy of Apatinib+Radiotherapy Vs. Radiotherapy Alone in Patients with Adv...
Efficacy of Apatinib+Radiotherapy Vs. Radiotherapy Alone in Patients with Adv...Efficacy of Apatinib+Radiotherapy Vs. Radiotherapy Alone in Patients with Adv...
Efficacy of Apatinib+Radiotherapy Vs. Radiotherapy Alone in Patients with Adv...
 
management of advanced cervical cancer [Autosaved].pptx
management of advanced cervical cancer [Autosaved].pptxmanagement of advanced cervical cancer [Autosaved].pptx
management of advanced cervical cancer [Autosaved].pptx
 
Neuroblastoma presentation
Neuroblastoma presentationNeuroblastoma presentation
Neuroblastoma presentation
 
Sacral chordoma
Sacral chordomaSacral chordoma
Sacral chordoma
 
Radiation-Induced Angiosarcoma of the Breast: Retrospective Analysis at a Reg...
Radiation-Induced Angiosarcoma of the Breast: Retrospective Analysis at a Reg...Radiation-Induced Angiosarcoma of the Breast: Retrospective Analysis at a Reg...
Radiation-Induced Angiosarcoma of the Breast: Retrospective Analysis at a Reg...
 
Radiation-Induced Angiosarcoma of the Breast: Retrospective Analysis at a Reg...
Radiation-Induced Angiosarcoma of the Breast: Retrospective Analysis at a Reg...Radiation-Induced Angiosarcoma of the Breast: Retrospective Analysis at a Reg...
Radiation-Induced Angiosarcoma of the Breast: Retrospective Analysis at a Reg...
 
RADIOTHERAPY FOR BREAST CANCER
RADIOTHERAPY FOR BREAST CANCERRADIOTHERAPY FOR BREAST CANCER
RADIOTHERAPY FOR BREAST CANCER
 
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
 
Stereotactic body radiotherapy
Stereotactic body radiotherapyStereotactic body radiotherapy
Stereotactic body radiotherapy
 

More from SinzianaIonescu1

More from SinzianaIonescu1 (20)

tumori cutanate.ppt
tumori cutanate.ppttumori cutanate.ppt
tumori cutanate.ppt
 
nicolae turnescu2.pptx
nicolae turnescu2.pptxnicolae turnescu2.pptx
nicolae turnescu2.pptx
 
prezentare caz tumora ovar giganta.ppt
prezentare caz tumora ovar giganta.pptprezentare caz tumora ovar giganta.ppt
prezentare caz tumora ovar giganta.ppt
 
protezarea anastomozelor bilio si pancreatico-jejunale dupa duodenopancreatec...
protezarea anastomozelor bilio si pancreatico-jejunale dupa duodenopancreatec...protezarea anastomozelor bilio si pancreatico-jejunale dupa duodenopancreatec...
protezarea anastomozelor bilio si pancreatico-jejunale dupa duodenopancreatec...
 
Surgical approach to intra-abdominal metastases from malignant melanoma
Surgical approach to intra-abdominal metastases from malignant melanomaSurgical approach to intra-abdominal metastases from malignant melanoma
Surgical approach to intra-abdominal metastases from malignant melanoma
 
Male breast cancer
Male breast cancerMale breast cancer
Male breast cancer
 
A liposarcoma of the retroperitoneum causing bowel obstruction
A liposarcoma of the retroperitoneum causing bowel obstructionA liposarcoma of the retroperitoneum causing bowel obstruction
A liposarcoma of the retroperitoneum causing bowel obstruction
 
A Krukenberg tumor causing bowel obstruction in a patient known with stage I...
A Krukenberg tumor causing bowel obstruction  in a patient known with stage I...A Krukenberg tumor causing bowel obstruction  in a patient known with stage I...
A Krukenberg tumor causing bowel obstruction in a patient known with stage I...
 
poster congres HPV Ionescu Sinziana leziuni neoplazice sincrone.ppt
poster congres HPV Ionescu Sinziana leziuni neoplazice sincrone.pptposter congres HPV Ionescu Sinziana leziuni neoplazice sincrone.ppt
poster congres HPV Ionescu Sinziana leziuni neoplazice sincrone.ppt
 
poster ESSO Budapesta melanom.ppt
poster ESSO Budapesta melanom.pptposter ESSO Budapesta melanom.ppt
poster ESSO Budapesta melanom.ppt
 
poster ESSO Budapesta colostoma.ppt
poster ESSO Budapesta colostoma.pptposter ESSO Budapesta colostoma.ppt
poster ESSO Budapesta colostoma.ppt
 
liposarcom caz mihaila congres IOB 2019.ppt
liposarcom caz mihaila congres IOB 2019.pptliposarcom caz mihaila congres IOB 2019.ppt
liposarcom caz mihaila congres IOB 2019.ppt
 
FORMAT 1 poster COGI three cancers .ppt
FORMAT 1 poster COGI three cancers .pptFORMAT 1 poster COGI three cancers .ppt
FORMAT 1 poster COGI three cancers .ppt
 
fever in the postoperative period .ppt
fever in the postoperative period .pptfever in the postoperative period .ppt
fever in the postoperative period .ppt
 
MARTHA TRANCU RAINER THE FIRST FEMALE SURGEON IN ROMANIA
MARTHA TRANCU RAINER THE FIRST FEMALE SURGEON IN ROMANIAMARTHA TRANCU RAINER THE FIRST FEMALE SURGEON IN ROMANIA
MARTHA TRANCU RAINER THE FIRST FEMALE SURGEON IN ROMANIA
 
ROMANIAN CONTRIBUTIONS TO THE SURGERY OF THE RECTUM-THOMA IONESCU
ROMANIAN CONTRIBUTIONS TO THE SURGERY OF THE RECTUM-THOMA IONESCUROMANIAN CONTRIBUTIONS TO THE SURGERY OF THE RECTUM-THOMA IONESCU
ROMANIAN CONTRIBUTIONS TO THE SURGERY OF THE RECTUM-THOMA IONESCU
 
ROMANIAN CONTRIBUTIONS TO THE HISTORY OF THE SURGERY OF PORTAL HYPERTENSION
ROMANIAN CONTRIBUTIONS TO THE HISTORY OF THE SURGERY OF PORTAL HYPERTENSIONROMANIAN CONTRIBUTIONS TO THE HISTORY OF THE SURGERY OF PORTAL HYPERTENSION
ROMANIAN CONTRIBUTIONS TO THE HISTORY OF THE SURGERY OF PORTAL HYPERTENSION
 
SOFIA IONESCU THE FIRST FEMALE NEUROSURGEON IN ROMANIA
SOFIA IONESCU THE FIRST FEMALE NEUROSURGEON IN ROMANIASOFIA IONESCU THE FIRST FEMALE NEUROSURGEON IN ROMANIA
SOFIA IONESCU THE FIRST FEMALE NEUROSURGEON IN ROMANIA
 
MARIA CUTARIDA CRATUNESCU THE FIRST WOMEN PHYSICIAN IN ROMANIA
MARIA CUTARIDA CRATUNESCU THE FIRST WOMEN PHYSICIAN IN ROMANIAMARIA CUTARIDA CRATUNESCU THE FIRST WOMEN PHYSICIAN IN ROMANIA
MARIA CUTARIDA CRATUNESCU THE FIRST WOMEN PHYSICIAN IN ROMANIA
 
PROFESSOR ION CHIRICUTA, A TALENTED SURGEON, A SKILLED MANAGER AND A DEDICATE...
PROFESSOR ION CHIRICUTA, A TALENTED SURGEON, A SKILLED MANAGER AND A DEDICATE...PROFESSOR ION CHIRICUTA, A TALENTED SURGEON, A SKILLED MANAGER AND A DEDICATE...
PROFESSOR ION CHIRICUTA, A TALENTED SURGEON, A SKILLED MANAGER AND A DEDICATE...
 

Recently uploaded

Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 

Recently uploaded (20)

Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
Young & Hot ℂall Girls Patna 8250077686 WhatsApp Number Best Rates of Patna ℂ...
Young & Hot ℂall Girls Patna 8250077686 WhatsApp Number Best Rates of Patna ℂ...Young & Hot ℂall Girls Patna 8250077686 WhatsApp Number Best Rates of Patna ℂ...
Young & Hot ℂall Girls Patna 8250077686 WhatsApp Number Best Rates of Patna ℂ...
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
 
Quality control tests of suppository ...
Quality control tests  of suppository ...Quality control tests  of suppository ...
Quality control tests of suppository ...
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptx
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
 
Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...
Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...
Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...
 
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas Hospital
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 

TUMOR RESPONSE TO RADIOTHERAPY IN RECTAL CANCER

  • 1. Various Aspects Of The Tumor Response To Radiotherapy In Rectal Cancer Authors: Prof. Dr. E. Bratucu Sinziana Ionescu Bucharest Oncology Institute
  • 2. Purpose And Goals  As rectal tumors answer in different grades to radiotherapy, we aim at evaluating –right from the moment of the biopsy- the capacity of the tumor to react or not to this treatment option  We find the immunohistochemical evaluation of the tumor to be of crucial importance and we highly recommend it to be done on the biopsy before radiotherapy
  • 3. Group Of Patients Studied Patient distribution by sex was equal between the two sexes, with 26 patients each. We examined tissue samples using paraffin blocks from 52 patients. The examinations were done comparatively, both: -before radiotherapy (tissues from diagnostic biopsy), as - after radiotherapy (tissues from abdomino-perineal resection). The patients had received treatment in the following units: Bucharest Oncology Institute, Coltea, Fundeni and Colentina Hospital The parametres studied were: A. histological and B. immunohistochemical
  • 4. A.Histological parameters studied Cell type distribution p=0.96 Distribution of the desmoplastic reaction p=0.218 Distribution of atypias p= 0.910 Distribution of the colloid type* p=0,001 * The only morphological parameter with statistical meaning, using the χ test with corresponding p value
  • 5. Cellular type  Cell shape and architecture are determined by interactions between the cell and the extracellular matrix and have profound effects on cellular behavior, chromatin condensation, and tumor cell resistance to radiotherapy and chemotherapy.  Transformation from cylindrical to cubic: oncocytic change in this particular clinical context occurs as a reflection of cytotoxic damage or cellular hypoxia induced by chemo-radiation resulting in degeneration of the cell and of the oncocytic phenotype.
  • 6. Cell type distribution before and after radiotherapy was predominantly cylindrical before radiotherapy(RIB) and cubic after radiotherapy (RIC) Cylindrical Cubic RIB 45 7 RIC 8 44 0 10 20 30 40 50 Cell type distribu on before and a er radiotherapy RIB RIC
  • 7. Desmoplastic reaction  Desmoplastic reaction has been defined as being associated with some tumors and is characterized by the pervasive growth of dense fibrous tissue around the tumor. This reaction makes it difficult to distinguish between spiculation in the perirectal fat caused by fibrosis alone from that caused by fibrous tissue that contains tumor cells. Cancer associated with a reactive stroma is typically diagnostic of poor prognosis.
  • 8. The distribution of desmoplastic reaction before and after radiotherapy: if before radiotherapy the predominant demoplastic reactions were of grades 1 and 2, after radiotherapy the predominant desmoplastic reaction becomes 1.
  • 9. Cellular atypia  Cellular atypias have been studied in the context of their association with increased severity of the neoplasm  The individual tumor cells in treated rectal cancer may show marked nuclear atypias .Marked cytoplasmic eosinophilia, often in association with nuclear atypias is the most commonly seen type of cytological alteration in tumors after radiation.
  • 10. The variation of the distribution of atypia before and after radiotherapy has kept the same type 2 as the main type of atypia
  • 11. Colloid type  Mucinous adenocarcinoma is characterised by abundant extracellular mucin produced by tumour cells. By definition, a 50% or greater mucinous component is required for the designation of mucinous colorectal carcinoma . The prognostic significance of mucinous carcinoma is controversial, many authors associating it with a poor prognosis in which regards chemoradiotherapy.
  • 14. Mucinous, Colloid and Signet ring cell types seen in the tissues after radiotherapy
  • 15. The variation in the distribution of the colloid response before and after radiotherapy changes consistently from dominant 0 to dominant 1.
  • 16. Colloid type  The increase of the colloid type from 0 to 1 would lead us towards the assumption that radiotherapy either induced or aggravated the expression of the colloid type  The literature used as reference showed that those cancers which appeared to have been induced by radiotherapy had mostly colloid features, therefore in a patient which was irradiated for prostate cancer , we could estimate weather the neoplasm appeared d’en blais or consequently to radiotherapy
  • 17. I.MARKERS OF STATISTICAL IMPORTANCE EGFR in the tumor (p=0.00045) EGFR in the normal epithelium (p=0.0017) VEGF in the tumor (p=0,0132) VEGF in the tumor stroma (p=0,030). P53 (p=0,044) B.Immunohistochemical parameters studied II.MARKERS WITHOUT STATISTICAL IMPORTANCE, WITH OBSERVATION-ONLY SIGNIFICANCE CK 7 P=0.6404 CK 20 P=0.278 E-cadherin P=0.368 Vimentin P value was not calculated, as all the tissues had the 0 value. CEA BCL 2 CYCLIN D1
  • 18. EGFR si VEGF-part 1  EGFR (epidermal growth factor receptor) exists on the cell surface as a transmembrane glycoprotein , a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family.and is activated by binding of its specific ligands, including epidermal growth factor and transforming growth factor α (TGFα). Mutations, amplifications or misregulations of EGFR or family members are implicated in about 30% of all epithelial cancers. The identification of EGFR as an oncogene has led to the development of anticancer therapeutics directed against EGFR, including gefitinib and erlotinib for lung cancer, and cetuximab for colon cancer.
  • 19. EGFR si VEGF part 2  Current findings have demonstrated that alterations in tumor stromal pathways, including the EGFR pathways, are associated with, and may contribute to, resistance to VEGF inhibitors and that targeting these pathways may improve therapeutic efficacy. Understanding stromal signaling may be critical for developing biomarkers for angiogenesis inhibitors and improving combination regimens and this is the reason why we chose to study EGFR and VEGF both at the level of the tumor and at the level of the stroma and the grades are given according to appreciation of two independent examining doctors regarding the amount of EGFR and VEGF in the tissue studied.
  • 20. The variation with radiotherapy of EGFR in the tumor: the tissues before radiotherapy had similar numbers of grades 1 and 2 and after radiotherapy grade 2 was the main grade found among the tissues examined EGFR in the tumor increased by a mean of 1 unit
  • 21. EGFR in the normal epithelium before and after radiotherapy 0 5 10 15 20 25 30 35 0 1 2 3 0 1 2 3 RIC 15 19 12 6 RIB 17 7 10 18 EGFR in the normal epithelium before and after radiotherapy RIC RIB
  • 22. Comparison between EGFR in the tissues before(RIB) and after radiotherapy(RIC) (RIB) (RIC)
  • 23. Comparison between EGFR in the tissues before(RIB) and after radiotherapy(RIC) (RIB) (RIC)
  • 25. Observation and specification of EGFR examination  EGFR in the normal stroma increases its expression in the smooth muscle and nervous fibres normal tissues which appear to be modified by irradiation with a χ of 0,0002 and a corresponding p value of 0.02.  These results (increased EGFR in the tumor, in the normal epithelium and in the normal stroma) may have clinical impact in a negative way, as patients with increased postradiotherapy EGFR had decreased overall survival and decreased disease free interval
  • 26. Comparison between VEGF in the tissues before(RIB) and after radiotherapy(RIC) RIB RIC in the normal mucosa RIC in the tumor
  • 27. VEGF in the tumor before and after radiotherapy
  • 28. VEGF in the tumor stroma before and after radiotherapy RIB RIC 0 5 10 15 20 25 GRADE 0 GRADE 1 GRADE 2 GRADE 3 RIB 12 10 11 19 RIC 10 22 12 8 VEGF in the tumor stroma RIB RIC
  • 29. Comparison between the VEGF values before and after radiotherapy at the tumor level(first pile to the left of the viewer) and at the level of the tumor stroma (pile at the right of the viewer). RIB 0 20 40 GRADE 0 GRADE 1 GRADE 2 GRADE 3 GRADE 0 GRADE 1 GRADE 2 GRADE 3 Varia on with radiotherapy of the values of the VEGF in the tumor and in the tumor stroma RIB RIC
  • 30. Observation  The increase of VEGF with radiotherapy in the tumor and in the tumor stroma was demonstrated also by other studies, those indicating the correlation between the increase in VEGF and: larger lymph node invasion, larger expansion of the tumor growth, bigger rate of radiation proctitis
  • 31. Out of 52 cases, in 4 , we have observed CEA becoming negative, a fact which could imply that in irradiated rectal tumors, a loss of the CEA expression would mislead us between a tumor which does not express it and a tumor that has disappeared with radiotherapy (we may mistake a change in tumor biology by a maximum tumor regression grade) CYCLIN D1 has a trend in becoming positive with radiotherapy. Cyclins regulate the progression of the cell through the cell cycle from G1 to S phase BCL2 shows a cell which is not able to enter an apoptosis. The expression of BCL-2 is lost in moderately and weakly differentiated tumors and kept in well differentiated ones. There is a vague increasing trend with radiotherapy from which we infer that radiotherapy would lead to a change in tumor biology. The integrity of the mitochondrial outer membrane is regulated by pro-apoptotic and anti-apoptotic members of the BCL2 family of proteins Observations regarding the parameters without statistical significance
  • 32. Conclusions part 1  The following morphological factors studied in our batch did not present with statistical significance so we could neither demonstrate nor quantify the influence of radiotherapy on them: cell type, desmoplastic reaction, atypias. On the other hand, the colloid type suffered a marked change with radiotherapy becoming in the majority of the cases from 0- 1 .  Other markers of statistical significance were EGFR at the tumor level, EGFR in the tumor stroma, EGFR in the normal epithelium and they all increased. Moreover, EGFR increased in expression in the smooth muscle fibers and nervous fibres demonstrating the involvement of the normal stroma in the response to radiotherapy . Another marker which was modified with radiotherapy was VEGF in the tumor and VEGF in the tumor stroma.
  • 33. Conclusions -part 2  The results are similar in trend to those in the scientific literature consulted in which concerns EGFR and VEGF.  Our study has a rather individual and original statement in comparison to those consulted using the pubmed index, in which concerns the stromal reaction to radiotherapy which could be more aggressive and statistically important than the reaction of the tumor tissues
  • 34. Limits and Perspectives  The most important limit of our study stands in the small number of cases , mostly in the situations in which we confronted with the problem of insufficient tissues  In which regards future improvements, apart from extending the number of cases for the markers studied , it would be interesting to find out their correlation between overall survival and the disease free interval in those patients.
  • 35. We thank Conferee Dr S.Zurac and Professor Dr. F.Staniceanu, from the pathology department of the Colentina Clinical Hospital for their special collaboration in our study "ACKNOWLEDGEMENT: This paper is supported by the Sectoral Operational Programme Human Resources Development (SOP HRD) 2007-2013, financed from the European Social Fund and by the Romanian Government under the contract number POSDRU/107/1.5/S/82839",